Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus management
$150 for Initial Consultation & Required Blood Work $399 Month to Month Program $1049 3 Month Program $1799 6 Month Program Are you looking for a long-lasting and effective weight loss solution?Semaglutide for weight loss might be just the thing for you
A bipartisan group of 38 AGs has already urged the FDA to intensify action, citing health risks from foreign-sourced counterfeit drugs
This large-scale, randomized, double-blind, placebo-controlled study included over 17,600 adults aged 45 years and older with established cardiovascular disease and without diabetes
What to expect week by week
Nausea incidence was around 20% initially, but many tolerated it well given once-weekly dosing leads to a lower peak concentration